Search bioRxiv⌕ Search

Biology subjects

Ramirez, M. F.

Publications and source records attributed to Ramirez, M. F..

3 recordsLinked to original sources

Nose-to-Brain Delivery of Cocaine in Mice: A Physiologically Based Pharmacokinetic Model Incorporating Olfactory Epithelial Transport, Mucociliary Clearance, and Blood-Brain Barrier Permeability

Intranasal (IN) cocaine produces rapid central nervous system (CNS) effects despite generating substantially lower plasma concentrations than equivalent intravenous (IV) doses, suggesting a direct nose-to-brain pathway. The olfactory epithelium provides anatomical continuity for cocaine to pass between the nasal cavity and the brain. Quantifying the relative contribution of this pathway to total brain cocaine exposure requires a physiologically-based pharmacokinetic (PBPK) model that explicitly accounts for nasal mucosal architecture, epithelial transport barriers, and blood-brain barrier (BBB) permeability. Here we used tandem mass spectrometry to collect cocaine concentration-time data from the brain and plasma of awake mice administered IV or IN cocaine and leveraged that data to generate such a framework. Our results provide evidence that following IN cocaine, the olfactory pathway accounts for approximately half of the cocaine that reaches the brain. The mechanistic PBPK framework developed here, incorporating anatomically grounded nasal compartment separation, blood-flow-scaled mucosal absorption, tissue diffusion resistance, mucociliary clearance, plasma protein binding, and BBB permeability-surface area transport, substantially improves upon empirical one-compartment absorption models and produces parameter estimates with physiological interpretability. The proportionate efficiency of the olfactory route relative to systemic absorption may provide a pharmacokinetic basis for the rapid onset of IN cocaines CNS effects and has direct implications for understanding the psychoactive effects of cocaine.

pharmacology and toxicology↗

Disruption of opioid and mesolimbic dopamine dynamics and behavior upon intranasal delivery of opioids in mice

The endogenous opioid system, consisting of mu, delta, and kappa opioid receptors, along with naturally occurring peptides, is central for regulating reward processing, mood, motivation, and social attachment. Endogenous opioids, as well as opioid drugs that are administered clinically or are misused/abused, are potent modulators of several neurotransmitter systems in the brain, including dopamine (DA). Since the opioid system is dysregulated in neuropsychiatric conditions, and opioids are prevalently misused/abused to achieve altered affective and cognitive states, the understanding of the mechanisms of action of opioids is highly significant. Unfortunately, there is no pre-clinical approach for understanding the actions of intranasally (IN) administered opioids, a common route of administration by both individuals with opioid use disorder and a route used clinically to achieve reversal of opioid overdose. Here we combined reliable and precise delivery of opioids into the nasal cavity of mice together with measures of opioid and DA dynamics in the nucleus accumbens (NAc) with fiber photometry, or, with measures of behaviors known impacted by opioids following other routes of administration, including respiration, to demonstrate the outcomes of IN opioids in mice. We uncovered a prompt and prolonged increase in mesolimbic DA by both IN morphine and fentanyl and the restoration of DA to baseline levels by subsequent IN opioid receptor antagonism with naloxone. Simultaneously, IN morphine and fentanyl each resulted in a short-lasting increase in NAc opioid dynamics. Next, in separate mice, we found that IN opioids elicit rapid canonical opioid-induced behaviors, including respiratory depression, which were rapidly reversed by IN naloxone. Overall, this work establishes a sensitive approach for evaluating the neural circuitry underlying opioid use disorder in a manner which recapitulates IN opioid use with ecological validity. Moreover, our findings point towards a likely important role for mesolimbic DA in mediating opioid overdose reversal.

neuroscience↗

In-dwelling microfluidic device for precise and reliable intranasal drug delivery during freely-moving behavior

Many substances/drugs are administered intranasally (IN). These include opioid overdose reversal drugs, anti-epileptic medications, migraine medications, hormone treatments, and medicines to treat/prevent allergies, colds, and flues including nasally-administered vaccines, corticosteroids, antihistamines, and decongestants. Additionally, IN administration is the preferred route of entry by users of illicit drugs. Despite the widespread use of the IN route of administration, there is no established paradigm to access this route of administration preclinically to yield precise and reliable control over delivery. This poses major gaps in therapeutic discovery/testing, establishing pharmacokinetic/pharmacodynamic relationships of therapeutics, and understanding the mechanisms of actions of therapeutics. We developed an in-dwelling microfluidic device, that, when implanted upon the nasal bone, accesses the nasal cavity to allow reliable and precise IN fluid delivery during freely-moving behavior. We validated this device, called the Nasal Access Port (NAP), to confirm it allows rapid and precise control of fluids. We further exemplified the application of the NAP for studying outcomes of IN cocaine in mice, including its pharmacokinetic profile, and both the rapid release of dopamine (DA) and behavioral effects upon IN cocaine. By achieving precise and reliable access to the IN route of administration, the NAP represents a significant methodological advance with broad applicability in the biomedical and life sciences, especially in the neuroscience, pharmacology, medicinal chemistry, and physiology domains.

pharmacology and toxicology↗